Ivana Magovcevic-liebisch - Net Worth and Insider Trading

Ivana Magovcevic-liebisch Net Worth

The estimated net worth of Ivana Magovcevic-liebisch is at least $2 Million dollars as of 2024-05-16. Ivana Magovcevic-liebisch is the EVP; COO of Dyax Corp and owns about 40,625 shares of Dyax Corp (DYAX) stock worth over $2 Million. Ivana Magovcevic-liebisch is the President and CEO of Vigil Neuroscience Inc and owns about 207,687 shares of Vigil Neuroscience Inc (VIGL) stock worth over $723,789. Ivana Magovcevic-liebisch is also the Director of Applied Genetic Technologies Corp and owns about 3,000 shares of Applied Genetic Technologies Corp (AGTC) stock worth over $1,181. Details can be seen in Ivana Magovcevic-liebisch's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ivana Magovcevic-liebisch has not made any transactions after 2023-11-20 and currently still holds the listed stock(s).

Transaction Summary of Ivana Magovcevic-liebisch

Ivana Magovcevic-liebisch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ivana Magovcevic-liebisch owns 5 companies in total, including Spyre Therapeutics Inc (SYRE) , Applied Genetic Technologies Corp (AGTC) , and Dyax Corp (DYAX) among others .

Click here to see the complete history of Ivana Magovcevic-liebisch’s form 4 insider trades.

Insider Ownership Summary of Ivana Magovcevic-liebisch

Ticker	Comapny	Transaction Date	Type of Owner
SYRE	Spyre Therapeutics Inc	2018-03-22	director
AGTC	Applied Genetic Technologies Corp	2016-11-16	director
DYAX	Dyax Corp	2013-03-29	EVP; Chief Operating Officer
		2021-07-21	director
		2023-11-20	director & President and CEO

Ivana Magovcevic-liebisch Latest Holdings Summary

Ivana Magovcevic-liebisch currently owns a total of 3 stocks. Among these stocks, Ivana Magovcevic-liebisch owns 40,625 shares of Dyax Corp (DYAX) as of March 6, 2013, with a value of $2 Million and a weighting of 68.28%. Ivana Magovcevic-liebisch owns 207,687 shares of Vigil Neuroscience Inc (VIGL) as of November 20, 2023, with a value of $723,789 and a weighting of 31.67%. Ivana Magovcevic-liebisch also owns 3,000 shares of Applied Genetic Technologies Corp (AGTC) as of November 16, 2016, with a value of $1,181 and a weighting of 0.05%.

Latest Holdings of Ivana Magovcevic-liebisch

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
DYAX	Dyax Corp	2013-03-06	40,625	38.41	1,560,406
VIGL	Vigil Neuroscience Inc	2023-11-20	207,687	3.49	723,789
AGTC	Applied Genetic Technologies Corp	2016-11-16	3,000	0.39	1,181

Holding Weightings of Ivana Magovcevic-liebisch

Ivana Magovcevic-liebisch Form 4 Trading Tracker

According to the SEC Form 4 filings, Ivana Magovcevic-liebisch has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the sale of 215,359 shares on March 6, 2013, which brought Ivana Magovcevic-liebisch around $861,436.

According to the SEC Form 4 filings, Ivana Magovcevic-liebisch has made a total of 2 transactions in Vigil Neuroscience Inc (VIGL) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vigil Neuroscience Inc is the acquisition of 4,000 shares on November 20, 2023, which cost Ivana Magovcevic-liebisch around $15,000.

According to the SEC Form 4 filings, Ivana Magovcevic-liebisch has made a total of 0 transactions in Applied Genetic Technologies Corp (AGTC) over the past 5 years. The most-recent trade in Applied Genetic Technologies Corp is the acquisition of 3,000 shares on November 16, 2016, which cost Ivana Magovcevic-liebisch around $28,890.

Insider Trading History of Ivana Magovcevic-liebisch

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ivana Magovcevic-liebisch Trading Performance

GuruFocus tracks the stock performance after each of Ivana Magovcevic-liebisch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ivana Magovcevic-liebisch is 25.08%. GuruFocus also compares Ivana Magovcevic-liebisch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ivana Magovcevic-liebisch within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ivana Magovcevic-liebisch's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ivana Magovcevic-liebisch

Average Return

Average return per transaction

Outperforming Transactions

2 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	0.27
Relative Return to S&P 500(%)	-2.34

Ivana Magovcevic-liebisch Ownership Network

Ownership Network List of Ivana Magovcevic-liebisch

No Data

Ownership Network Relation of Ivana Magovcevic-liebisch

Ivana Magovcevic-liebisch Owned Company Details

What does Spyre Therapeutics Inc do?

Who are the key executives at Spyre Therapeutics Inc?

Ivana Magovcevic-liebisch is the director of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .

Spyre Therapeutics Inc (SYRE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Spyre Therapeutics Inc Insider Transactions

No Available Data

What does Applied Genetic Technologies Corp do?

Who are the key executives at Applied Genetic Technologies Corp?

Ivana Magovcevic-liebisch is the director of Applied Genetic Technologies Corp. Other key executives at Applied Genetic Technologies Corp include Chief Medical Officer Susan Schneider , Chief Financial Officer Jonathan I Lieber , and See Remarks Stephen W Potter .

Applied Genetic Technologies Corp (AGTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Applied Genetic Technologies Corp Insider Transactions

No Available Data

What does Dyax Corp do?

Who are the key executives at Dyax Corp?

Ivana Magovcevic-liebisch is the EVP; Chief Operating Officer of Dyax Corp. Other key executives at Dyax Corp include CMO & EVP & R&D Burt A Adelman , other: Former director David J Mclachlan , and other: Former director Paolo Pucci .

Dyax Corp (DYAX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dyax Corp (DYAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dyax Corp (DYAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dyax Corp (DYAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dyax Corp Insider Transactions

No Available Data

What does Absci Corp do?

Who are the key executives at Absci Corp?

Ivana Magovcevic-liebisch is the director of Absci Corp. Other key executives at Absci Corp include director & 10 percent owner Redmile Group, Llc , General Counsel Sarah Korman , and VP & CCPAO Todd Bedrick .

Absci Corp (ABSI) Insider Trades Summary

Over the past 18 months, Ivana Magovcevic-liebisch made no insider transaction in Absci Corp (ABSI). Other recent insider transactions involving Absci Corp (ABSI) include a net purchase of 222,222 shares made by Redmile Group, Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Absci Corp (ABSI) in total and bought 222,222 shares, with a net purchase of 222,222 shares. During the past 18 months, 0 shares of Absci Corp (ABSI) were sold and 222,222 shares were bought by its insiders, resulting in a net purchase of 222,222 shares.

Absci Corp (ABSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Absci Corp Insider Transactions

No Available Data

What does Vigil Neuroscience Inc do?

Who are the key executives at Vigil Neuroscience Inc?

Ivana Magovcevic-liebisch is the director & President and CEO of Vigil Neuroscience Inc. Other key executives at Vigil Neuroscience Inc include Chief Medical Officer Christopher Silber , Chief Science Officer Gray David L. F. , and Chief Medical Officer Spyridon Papapetropoulos .

Vigil Neuroscience Inc (VIGL) Insider Trades Summary

Over the past 18 months, Ivana Magovcevic-liebisch made 1 insider transaction in Vigil Neuroscience Inc (VIGL) with a net purchase of 4,000. Other recent insider transactions involving Vigil Neuroscience Inc (VIGL) include a net sale of 300 shares made by Spyridon Papapetropoulos ,

In summary, during the past 3 months, insiders sold 0 shares of Vigil Neuroscience Inc (VIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300 shares of Vigil Neuroscience Inc (VIGL) were sold and 4,000 shares were bought by its insiders, resulting in a net purchase of 3,700 shares.

Vigil Neuroscience Inc (VIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vigil Neuroscience Inc Insider Transactions

No Available Data

Ivana Magovcevic-liebisch Mailing Address

Above is the net worth, insider trading, and ownership report for Ivana Magovcevic-liebisch. You might contact Ivana Magovcevic-liebisch via mailing address: 300 Technology Square, 8th Floor, Cambridge Ma 02139.

Discussions on Ivana Magovcevic-liebisch

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.